iRhythm (IRTC) stock slides as 2026 outlook and holding-company switch land
New York, Jan 13, 2026, 14:56 (EST) — Regular session Shares of iRhythm Technologies (IRTC) fell 7.5% to $156.24 in Tuesday afternoon trading, following the company’s release of its 2026 sales and profitability goals alongside a plan for corporate restructuring. The timing is key. The update landed right in the middle of the J.P. Morgan Healthcare Conference in San Francisco, a week when medtech and biotech firms typically shape the year’s initial outlook. iRhythm is working hard to reassure investors it can sustain growth as it pushes toward profitability. The company hasn’t published its full 2025 results yet, leaving the